Report Highlights
The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027.
Report Includes
- 33 data tables and 33 additional tables
- An up-to-date review of the global markets for stents and associated medical device technologies
- Analyses of the global market trends, with revenue sales data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Evaluation and forecast the global stents market size, forecasted growth trends, and corresponding market share analysis by product type, therapeutic application, and geographic region
- Identification of promising new products (stents) and technologies which are still in development and assess the probability of their successful commercialization over the next few years
- In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of global stents marketplace
- Discussion of the regulatory structure for medical stents, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the medical devices industry
- Insight into recent industry structure, competitive landscape for major types of stents manufacturers, ongoing research activities and their clinical trials
- Key merger and acquisition deals, product approvals/launches, agreements, collaborations, and other strategic alliances within the MedTech industry
- Descriptive company profiles of the leading global players, including Abbott Laboratories, B. Braun Melsungen AG, BD, Biotronik SE, Boston Scientific Corp., Cook Medical LLC, Medtronic plc and Terumo Corp.
Report Scope
This report aims to provide a comprehensive study of the global market for stents, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding stent devices.
An in-depth analysis of the global stents market includes historical data and market projection on sales by product type, application, and region. It describes different types of stents (bare metal, drug-eluting, bioabsorbable, and others) and their current and historical market revenues. This report also categorizes the global stents market based on application (vascular and nonvascular). The vascular stents market is divided into coronary and peripheral vascular. Peripheral vascular stents are segmented into peripheral lower extremity, carotid and intracranial and renal. Peripheral lower extremity is further segmented as iliac and other lower extremities. The nonvascular stent market is divided into ureteral, gastrointestinal (colorectal, esophageal, duodenal), bile duct/pancreatic and tracheobronchial/pulmonary.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares. The report also discusses technological trends and new product developments.
The scope of this report does not include endovascular graft/stent grafts indicated for aortic and other types of aneurysm treatment and for use in the treatment of free perforations or ruptures.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||
Forecast period considered | 2027 | ||||||||||||
Base year market size | $7.4 billion | ||||||||||||
Market size forecast | $9.7 billion | ||||||||||||
Growth rate | CAGR of 4.3% for the forecast period of 2022-2027 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | product, application, and region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific and Rest of World (RoW) | ||||||||||||
Countries covered | United States, Canada, Germany, France, U.K., Italy, Japan, China, and India | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Electric Vehicle Battery Reuse and Recycling Market (FCB058B)
- Artificial Intelligence (AI) in Cancer (BIO196B)
- Nutraceuticals: Global Markets (FOD013J)
- Protective Relays and Circuit Breakers: Global Markets (IAS157B)
- Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)
Report Highlights
The global stents market was $7.9 billion in 2013 and 8.1 $billion in 2014. This market is expected to grow to about $10.6 billion in 2019, with a compound annual growth rate (CAGR) of 5.7%.
Report Includes
- An overview of the global market for stent technologies.
- Analyses of global market trends, with data from 2013, 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Segmentation of the market by products, stents design/material, and applications; the products sector is further segmented by types of devices: vascular and nonvascular; the design/material sector is segmented into four types: bare-metal stents, drug-eluting stents, bioabsorbable stents, and others (plastic).
- Discussion of the role of stents in vascular disease treatment, with an overview of peripheral vascular disease and cardiovascular disease.
- Market dynamics, such as drivers, restraints and challenges, and opportunities
- A cost-benefit analysis.
- Patent analysis.
- Comprehensive company profiles of major players in the industry.
Related Reports
Global Markets for Drug-Device Combinations
The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.
Global Vascular Patches Market
The global vascular patches market reached $717.4 million in 2022 and should reach $1 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Global Markets for Catheters
The global market for catheters is estimated to increase from $30.8 billion in 2022 to reach $42.5 billion by 2027, at a compound annual growth rate (CAGR) of 6.6% from 2022 through 2027.
Global Drug-Eluting Stents Market
The global market for drug-eluting stents should grow from $6.7 billion in 2019 to $9.3 billion by 2024 at a compound annual growth rate (CAGR) of 6.8% during the period of 2019-2024.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More